Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults

Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.

• CJC-1295 with DAC 5mg

  GHRH analog with drug-affinity complex. Extended-half-life GH-axis research peptide.
  View product →
• CJC-1295 (no DAC)

  Modified GHRH (1-29) analog without drug-affinity complex. Short half-life GH-axis research peptide.
  View product →

• CJC-1295 with DAC — the other molecule, and how to tell them apart
  The DAC form is 279 daltons heavier than the no-DAC form and has its own CAS. One number on the COA separates them.
  2 min read
• Sermorelin — GHRH (1-29) and the peptide family built on it
  Sermorelin is the unmodified first 29 residues of growth hormone releasing hormone. Every GHRH analog in this market is a modification of it.
  2 min read
• White label, private label, contract manufacturing — the difference
  Three terms used interchangeably that mean different things commercially. Which one you actually want depends on who owns the formulation and who carries the inventory.
  3 min read
• Choosing a US peptide supplier for a clinic or store
  What separates suppliers when everyone's website says the same thing: where the material is made, who tests it, and what they will put in writing.
  3 min read